The Liver Meeting 2019-Clinical Vs Science in Personalizing Immunosuppression

Clinical Vs Science in Personalizing Immunosuppression

Video Transcription

Video Summary

In the video transcript, Professor Avi Shaked discusses the advancements and challenges in liver transplantation, focusing on immunosuppression. He highlights the improvements in transplant outcomes over the years and emphasizes the importance of managing immunosuppression effectively. Professor Shaked introduces the concept of personalized immunosuppression and discusses the need to tailor treatment to each patient to minimize complications. He presents studies on identifying biomarkers for rejection before organ injury occurs, indicating the potential for personalized immunosuppression based on molecular signatures. He also reflects on the legacy of renowned transplant surgeon Tom Starzl, who was a pioneer in the field of immunosuppression. Overall, the transcript emphasizes the ongoing research and potential for improved immunosuppression strategies in liver transplantation.

Asset Caption

Presenter: Abraham Shaked

Keywords

liver transplantation

immunosuppression

advancements

challenges

personalized treatment

biomarkers

Tom Starzl